REBECCA CAO: Open Payments
NPI 1558041327 · LEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 23 payments from 15 companies in 2025. Trend: 2023 $659 · 2024 $998 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $167 |
| Lilly USA, LLC | 1 | $103 |
| Novo Nordisk Inc | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $48 |
| Lundbeck LLC | 1 | $33 |
| Exact Sciences Corporation | 1 | $30 |
| PFIZER INC. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: REPATHA, ZEPBOUND, GEMTESA, ABILIFY ASIMTUFII, EVENITY, REXULTI, Cologuard Collection Kit, Ozempic.
Industry payments across MA — which companies pay providers there.
